The implications of 3-parent mitochondrial therapy (2 mothers and 1 father) whose collateral effects in the new being are still unknown.
Mitochondrial transfer (modified mitochondrial therapy) was recently approved in the United Kingdom. Now, a group of investigators from the National Academy of Medicine in the United States have also proposed that this practice be legalised in North America. However, it must be approved by the US Food and Drug Administration, which has still not occurred as a result of the as yet not fully controlled consequences that this practice may have. Therefore, for now, the group of investigators who proposed legalising this practice suggest limiting it to male embryos, since the offspring thus produced would be unable to transfer modified mitochondria to future generations (Scientific American. Sara Reardon. 8-II-2016).
La entrada Mitochondrial therapy. United States have also proposed this practice be legalise despite collateral effects in the new being are still unknown aparece primero en Observatorio de Bioética, UCV.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.